GEHC vs. ZBH: GE HealthCare vs. Zimmer Biomet Stock Comparison

Company Profile

GE HealthCare (GEHC) and Zimmer Biomet (ZBH) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Zimmer Biomet (ZBH) has more than two decades of public-market history since July 25, 2001, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

GE HealthCare (GEHC) at 20.01% sits in the top ROE quartile, while Zimmer Biomet (ZBH) at 6.03% is closer to the peer norm — stronger capital efficiency for GEHC.

GE HealthCare (GEHC) at 9.95% retains a top-quartile share of revenue as profit, ahead of Zimmer Biomet (ZBH) at 8.95%, which keeps about the industry-typical share.

Both GE HealthCare (GEHC) at 15.33% and Zimmer Biomet (ZBH) at 17.35% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both GE HealthCare (GEHC) at 4.84% and Zimmer Biomet (ZBH) at 7.20% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both GE HealthCare (GEHC) at 4.84% and Zimmer Biomet (ZBH) at -19.86% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Zimmer Biomet (ZBH) at 1.46 keeps current ratio within its industry’s typical mid-range, while GE HealthCare (GEHC) at 1.30 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for GEHC.

Both GE HealthCare (GEHC) at 0.88 and Zimmer Biomet (ZBH) at 0.60 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Both GE HealthCare (GEHC) at 0.17% and Zimmer Biomet (ZBH) at 0.90% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both GE HealthCare (GEHC) at 2.96% and Zimmer Biomet (ZBH) at 24.24% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while Zimmer Biomet (ZBH) at 26.66 is closer to its industry’s usual earnings multiple — a discount for GEHC, though growth and earnings durability still matter.

On P/S ratio, both GE HealthCare (GEHC) at 1.72 and Zimmer Biomet (ZBH) at 2.33 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Zimmer Biomet (ZBH) at 1.58 sits in the lower P/B ratio quartile against book while GE HealthCare (GEHC) at 3.21 is valued near its industry’s middle — ZBH is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics